- Home
- TPR vs BIIB Comparison
TPR vs BIIB Comparison
Compare TPR & BIIB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TPR
- BIIB
- Stock Information
- Founded
- TPR 1941
- BIIB 1978
- Country
- TPR United States
- BIIB United States
- Employees
- TPR N/A
- BIIB N/A
- Industry
- TPR Apparel
- BIIB Biotechnology: Pharmaceutical Preparations
- Sector
- TPR Consumer Discretionary
- BIIB Health Care
- Exchange
- TPR Nasdaq
- BIIB Nasdaq
- Market Cap
- TPR 20.8B
- BIIB 24.2B
- IPO Year
- TPR 2000
- BIIB 1991
- Fundamental
- Price
- TPR $109.55
- BIIB $181.70
- Analyst Decision
- TPR Buy
- BIIB Buy
- Analyst Count
- TPR 18
- BIIB 23
- Target Price
- TPR $117.00
- BIIB $176.48
- AVG Volume (30 Days)
- TPR 3.7M
- BIIB 2.0M
- Earning Date
- TPR 11-06-2025
- BIIB 10-30-2025
- Dividend Yield
- TPR 1.46%
- BIIB N/A
- EPS Growth
- TPR N/A
- BIIB N/A
- EPS
- TPR 1.25
- BIIB 10.97
- Revenue
- TPR $7,207,800,000.00
- BIIB $10,065,900,000.00
- Revenue This Year
- TPR $4.06
- BIIB $2.97
- Revenue Next Year
- TPR $4.48
- BIIB N/A
- P/E Ratio
- TPR $87.37
- BIIB $16.59
- Revenue Growth
- TPR 8.14
- BIIB 4.77
- 52 Week Low
- TPR $58.39
- BIIB $110.04
- 52 Week High
- TPR $118.56
- BIIB $185.17
- Technical
- Relative Strength Index (RSI)
- TPR 54.17
- BIIB 80.16
- Support Level
- TPR $104.50
- BIIB $165.75
- Resistance Level
- TPR $111.82
- BIIB $183.93
- Average True Range (ATR)
- TPR 3.56
- BIIB 5.46
- MACD
- TPR 1.01
- BIIB 1.68
- Stochastic Oscillator
- TPR 80.57
- BIIB 89.52
About TPR Tapestry Inc.
Based in New York City, Tapestry is the parent company of accessories and fashion brand Coach, which accounted for 80% of its revenue and well over 90% of its operating profit in fiscal 2025. Handbags accounted for 58% of the brand's fiscal 2025 revenue. Coach products are sold through more than 900 company-owned stores, e-commerce, and third-party stores in North America, Asia, and Europe. Tapestry also owns Kate Spade (17% of fiscal 2025 revenue), which operates about 170 stores and generated 52% of its sales from handbags in fiscal 2025. Kate Spade is known for its colorful patterns and graphics. Tapestry sold its smallest brand, luxury footwear maker Stuart Weitzman, to Caleres in August 2025.
About BIIB Biogen Inc.
Biogen is an established biopharmaceutical company focused on treatments for neurological diseases and rare diseases. Its declining multiple sclerosis franchise is its largest revenue generator and contributed 45% of total revenue in 2024. Biogen also generates significant revenue from its CD20 collaboration agreements with Roche (18% of total in 2024), which includes oncology drugs Rituxan and Gazyva and multiple sclerosis drug Ocrevus. Biogen's newer franchises include Spinraza (spinal muscular atrophy, with partner Ionis), Leqembi (Alzheimer's disease, collabroation revenue from its partner Eisai), Skyclarys (Friedreich's ataxia, Reata), Zurzuvae (postpartum depression, Sage), and Qalsody (amyotrophic lateral sclerosis, Ionis).